Jennifer Keiser
Clinical trials sponsored by Jennifer Keiser, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for kids with liver fluke: drug trial launches Results expected Oct 2026 (estimated)
- New whipworm drug could beat standard treatment in one dose Results expected Jan 2027 (estimated)
-
New combo drug doses aim to wipe out whipworm in toddlers
Disease control CompletedThis study tested whether higher doses of ivermectin, combined with albendazole, are safe and effective for treating whipworm infections in children aged 2 to 5 years. The trial involved 260 children in Tanzania and compared different doses of ivermectin, including a new dissolva…
Phase 2 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a Two-Drug punch finally knock out whipworm in kids?
Disease control CompletedThis study tested whether combining two drugs—moxidectin and albendazole—works better than albendazole alone for treating whipworm infections in children aged 6 to 12. The trial took place in Tanzania and involved 224 children. Researchers measured how many children were cured an…
Phase 3 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated Jun 26, 2026 19:06 UTC